Table 1. Properties of microRNAs differentially expressed in atherosclerotic CAD patients compared with healthy control subjects.

miRNA	Fold change	P value	Chromosome location	Potential targets
Upregulated
miR-20b-5p	4.73	<0.0001	Xq26.2	MLL5, THRA
miR-138-1-3p	3.79	<0.0001	3p21.32	PCNT, BMP
miR-499a-3p	18.97	<0.0001	20q11.22	MEF2C, FOXN3
miR-218-2-3p	10.37	<0.01	5q34	GLCE, TUB
miR-142-5p	7.47	<0.01	17q22	AFF4, MKL2
miR-147b	6.12	<0.001	9q33.2	IGF2, INS
miR-135b-5p	6.43	<0.001	1q32.1	MEF2C, FOXN3
miR-302f	14.8	<0.001	18q12.1	GGCX, PROSC
ebv-miR-BART7-5p	4.43	<0.001
miR-155	1.21	0.414	21q21.3	UACA, ZIC3
Downregulated
miR-21	0.135	<0.0001	17q23.1	NFIB, PPARA
miR-98	0.13	<0.01	Xp11.22	PAPPA, PTPRD
miR-379	0.132	<0.0001	14q32.31	FIGN, HLCS